Sign In
Buy MRK
$113.87
-1.62 (-1.40%)
At Close: Jun 18, 2026
Merck Scraps Two Late-Stage Keytruda Studies on Disappointing Data
01:06pm, Friday, 30'th Aug 2024
MRK made this decision after an independent committee pointed out that Keytruda did not show improvement in certain types of lung and skin cancers.
Merck scraps two late-stage trials of cancer drug Keytruda
03:38pm, Thursday, 29'th Aug 2024
Merck has stopped two separate late-stage studies of its immunotherapy Keytruda in patients with skin and lung cancers, the company said on Thursday, marking the latest set of trial failures for the b
Why Is Merck (MRK) Up 3.8% Since Last Earnings Report?
12:37pm, Thursday, 29'th Aug 2024
Merck (MRK) reported earnings 30 days ago. What's next for the stock?
Merck Provides Update on Phase 3 KEYNOTE-867 and KEYNOTE-630 Trials
06:30am, Thursday, 29'th Aug 2024
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today provided updates on two Phase 3 trials, KEYNOTE-867 and KEYNOTE-630. Merck i
MRK Begins 2nd Phase III Study on Rare Blood Disorder Candidate
01:50pm, Wednesday, 28'th Aug 2024
Merck begins the second phase III study on its LSD1 inhibitor, bomedemstat, for treating certain patients with essential thrombocythemia, a rare blood disorder.
Merck Stock Worth Watching on PAH Drug Winrevair's Approval in Europe?
11:01am, Tuesday, 27'th Aug 2024
MRK's Winrevair becomes the first novel activin signaling inhibitor therapy approved in Europe to treat PAH.
RAHWAY, N.J.--(BUSINESS WIRE)--Merck Announces Phase 3 Trial Initiation for Bomedemstat, an Investigational Candidate for Certain Patients With Essential Thrombocythemia.
The Zacks Analyst Blog Costco, Merck & Co., Linde, Hamilton Beach Brands and Armanino Foods of Distinction
10:55am, Monday, 26'th Aug 2024
Costco, Merck & Co., Linde, Hamilton Beach Brands and Armanino Foods of Distinction are included in this Analyst Blog.
Fertility-related stocks are becoming more attractive, Barclays says
10:11pm, Sunday, 25'th Aug 2024
CNBC's Silvia Amaro takes a look at why investors are growing more interested in fertility-related stocks.
Merck (MRK) Falls 10% in 3 Months: Should You Buy the Dip?
11:25am, Friday, 23'rd Aug 2024
Declining estimates and the recent price drop make investors skeptical about holding Merck's (MRK) stock.
Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock
10:05am, Friday, 23'rd Aug 2024
Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.
Merck (MRK) Could Be a Great Choice
12:45pm, Wednesday, 21'st Aug 2024
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Merck (MRK) have what it takes?
Is Merck Stock A Better Pick Over AbbVie?
05:00am, Wednesday, 21'st Aug 2024
We believe that the pharmaceuticals giant Merck (NYSE: MRK) is currently a better pick over its peer, AbbVie stock. MRK stock trades at 14x forward earnings, versus 20x for ABBV.
Merck's Stock Dip Offers a Buying Opportunity: Here's Why
08:32am, Tuesday, 20'th Aug 2024
Global big pharmaceutical company Merck & Co. Inc. NYSE: MRK shares sank 9% following its Q2 2024 earnings release. Merck beat top and bottom line estimates, but the lowered full-year EPS 2024 guidanc
Top 10 pharmaceutical companies in 2024: S&P Global's latest ratings and rankings
01:57pm, Monday, 19'th Aug 2024
In the ever-evolving pharmaceutical landscape, financial stability and business resilience are crucial for long-term success. S&P Global, a leading financial information firm, recently released a comp
